PEPperPRINT GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on AutoimmunityHEIDELBERG, Germany, June 09, 2022 / B3C newswire / PEPperPRINT GmbH, an innovative and award-winning biotech company and the leading provider of high-density peptide microarrays fo.
08.06.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 08.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to . Seite 1
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.